International Society for Pharmaceutical Engineering (ISPE)

6110 Executive Blvd.
20852 North Bethesda
US

Contact WebSite

Article

503A Compounding – Regulatory Basis and Industry Good Practices for Pharmacies
24.05.2024 • Whitepaper

503A Compounding – Regulatory Basis and Industry Good Practices for Pharmacies

A recently released guidance document, ISPE Guide: 503A Compounding – Regulatory Basis and Industry Good Practices for Pharmacies, summarizes and contextualizes key information from US governmental bodies relevant to 503A pharmacies.

Shaping the Future of the Pharma Industry
02.05.2022 • NewsChemistry

Shaping the Future of the Pharma Industry

The International Society for Pharmaceutical Engineering (ISPE) announced the 2022 Facility of the Year Awards (FOYA) Category Winners – including an Honorable Mention for Iovance Biotherapeutics, to be the first company in the world to commercially produce a personalized therapy for solid tumors.

Janssen Sciences Ireland is Overall Winner of ISPE’s 2021 Facility of the Year Awards
03.11.2021 • News

Janssen Sciences Ireland is Overall Winner of ISPE’s 2021 Facility of the Year Awards

The International Society for Pharmaceutical Engineering (ISPE) has announced Janssen Sciences Ireland as the 2021 Facility of the Year Awards (FOYA) Overall Winner.

A Roadmap for Pharma 4.0
07.09.2021 • NewsStrategy

A Roadmap for Pharma 4.0

Industry experts Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 group – talk about the idea behind ISPE’s Pharma 4.0 initiative and the challenges on the way to realize the digital transformation of the pharmaceutical industry.

Innovation and Creativity in the Pharmaceutical Industry
30.04.2021 • NewsChemistry

Innovation and Creativity in the Pharmaceutical Industry

The International Society for Pharmaceutical Engineering (ISPE) announced the 2021 Facility of the Year Awards (FOYA) Category Winners—including two winners of Special Recognition Awards for Operational Agility: Covid-19 Impact.